DK1277466T3 - Plaster indeholdende et antiinflammatorisk middel - Google Patents
Plaster indeholdende et antiinflammatorisk middelInfo
- Publication number
- DK1277466T3 DK1277466T3 DK01919982.7T DK01919982T DK1277466T3 DK 1277466 T3 DK1277466 T3 DK 1277466T3 DK 01919982 T DK01919982 T DK 01919982T DK 1277466 T3 DK1277466 T3 DK 1277466T3
- Authority
- DK
- Denmark
- Prior art keywords
- mass
- test
- antiinflammatory
- molecular weight
- inflammatory agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Botany (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000116744 | 2000-04-18 | ||
| PCT/JP2001/003283 WO2001078690A1 (en) | 2000-04-18 | 2001-04-17 | Patch containing anti-inflammatory agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1277466T3 true DK1277466T3 (da) | 2011-10-17 |
Family
ID=18628168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01919982.7T DK1277466T3 (da) | 2000-04-18 | 2001-04-17 | Plaster indeholdende et antiinflammatorisk middel |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20030149383A1 (da) |
| EP (1) | EP1277466B1 (da) |
| JP (1) | JP4854163B2 (da) |
| KR (1) | KR100600456B1 (da) |
| CN (1) | CN1200696C (da) |
| AT (1) | ATE517614T1 (da) |
| BR (1) | BR0110178A (da) |
| CA (1) | CA2406261C (da) |
| DK (1) | DK1277466T3 (da) |
| ES (1) | ES2367541T3 (da) |
| PT (1) | PT1277466E (da) |
| TW (1) | TWI283587B (da) |
| WO (1) | WO2001078690A1 (da) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001043729A1 (fr) * | 1999-12-15 | 2001-06-21 | Hisamitsu Pharmaceutical Co., Inc. | Preparations d'adhesifs |
| FR2838745B1 (fr) * | 2002-04-17 | 2004-07-09 | Urgo Laboratoires | Emulsions solides a base d'elastomere thermoplastique |
| AU2003272878A1 (en) * | 2002-09-13 | 2004-04-30 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive patch |
| US8034374B2 (en) * | 2003-03-18 | 2011-10-11 | Hisamitsu Pharmaceutical Co., Inc. | Patch containing nonsteroidal anti-inflammatory and analgesic agent |
| TWI327074B (en) * | 2003-05-07 | 2010-07-11 | Hisamitsu Pharmaceutical Co | Ultra violet shielding patch |
| US7476222B2 (en) * | 2003-06-30 | 2009-01-13 | Johnson & Johnson Consumer Companies, Inc. | Methods of reducing the appearance of pigmentation with galvanic generated electricity |
| BRPI0415652B8 (pt) * | 2003-10-20 | 2021-07-27 | Hisamitsu Pharmaceutical Co | composição adesiva sensível à pressão |
| DE10357321A1 (de) | 2003-12-05 | 2005-07-21 | Tesa Ag | Hochtackige Klebmasse, Verfahren zu deren Herstellung und deren Verwendung |
| TWI341736B (en) | 2003-12-26 | 2011-05-11 | Hisamitsu Pharmaceutical Co | Anti-infammatory adhesive preparations |
| TW200613004A (en) * | 2004-08-31 | 2006-05-01 | Aspion Co Ltd | External preparation of solid/oil type |
| KR101121890B1 (ko) * | 2004-11-05 | 2012-03-19 | 리도 케미칼 가부시키가이샤 | 비스테로이드 소염 진통약을 함유하는 비수계 경피흡수제제 |
| JP4869583B2 (ja) * | 2004-11-30 | 2012-02-08 | 久光製薬株式会社 | 角質剥離が少ない貼付剤 |
| JP2006206471A (ja) * | 2005-01-26 | 2006-08-10 | Nitto Denko Corp | テープ製剤 |
| JP5117846B2 (ja) * | 2005-02-25 | 2013-01-16 | 久光製薬株式会社 | 抗炎症剤及び大豆レシチンを含有する外用剤 |
| BRPI0607464B8 (pt) * | 2005-03-10 | 2021-06-22 | Hisamitsu Pharmaceutical Co | adesivo e emplastro adesivo |
| US20060263420A1 (en) * | 2005-03-10 | 2006-11-23 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive and plaster |
| JP5089376B2 (ja) * | 2005-03-10 | 2012-12-05 | 久光製薬株式会社 | 粘着剤及び貼付剤 |
| JP4921739B2 (ja) * | 2005-08-10 | 2012-04-25 | 久光製薬株式会社 | 皮膚刺激を低減した貼付剤 |
| JP5684441B2 (ja) * | 2005-12-28 | 2015-03-11 | 久光製薬株式会社 | インドメタシン含有貼付剤 |
| CN101896175B (zh) * | 2007-12-12 | 2013-03-13 | 帝国制药株式会社 | 含有环氧洛芬的水性贴剂 |
| CN101502499B (zh) * | 2009-03-13 | 2011-07-27 | 北京化工大学 | 一种布洛芬经皮释放贴剂及其制备方法 |
| CN102933209B (zh) * | 2010-04-13 | 2015-06-17 | 东亚合成株式会社 | 医疗用粘合剂组合物、医疗用贴剂和该组合物的制备方法 |
| JP6014813B2 (ja) * | 2010-09-03 | 2016-10-26 | 株式会社 ケイ・エム トランスダーム | 経皮吸収製剤および皮膚貼付用粘着シート |
| ES2669306T3 (es) * | 2010-11-02 | 2018-05-24 | Teikoku Seiyaku Co., Ltd. | Parche externo que contiene felbinaco |
| CN103849100A (zh) * | 2012-12-03 | 2014-06-11 | 中国石油化工股份有限公司 | 一种用于膏药或贴剂的载体苯乙烯-异戊二烯嵌段共聚组合物及胶粘剂的制备 |
| JP5767417B1 (ja) | 2015-02-05 | 2015-08-19 | 久光製薬株式会社 | 貼付剤 |
| CN106692110B (zh) * | 2015-08-19 | 2019-12-17 | 天津市山佳医药科技有限公司 | 一种芳基丙酸类非甾体抗炎药贴剂及其制备方法 |
| CN106692111A (zh) * | 2015-11-13 | 2017-05-24 | 北京泰德制药股份有限公司 | 一种含有酮洛芬的皮肤外用贴剂及其制备方法 |
| CN106822049B (zh) * | 2015-12-07 | 2020-10-20 | 北京乳凝创智生物技术研发中心(有限合伙) | 新型化药贴剂酮洛芬贴片及其制备方法 |
| EP3301133A1 (en) | 2016-09-29 | 2018-04-04 | ARLANXEO Canada Inc. | Multi-modal polyisoolefin compositions and processes for their production |
| EP3528795A1 (de) * | 2016-10-18 | 2019-08-28 | LTS Lohmann Therapie-Systeme AG | Zweischichtiges topisches therapeutisches system |
| ES2893527T3 (es) | 2016-12-28 | 2022-02-09 | Hisamitsu Pharmaceutical Co | Parche |
| US11872320B2 (en) | 2021-02-25 | 2024-01-16 | Hisamitsu Pharmaceutical Co., Inc. | Method for treating osteoarthritis |
| US20230120384A1 (en) * | 2021-10-19 | 2023-04-20 | Heather Sloan | Menthol- and magnesium-infused kinesiology tape |
| DE102021128912A1 (de) * | 2021-11-05 | 2023-05-11 | Lts Lohmann Therapie-Systeme Ag. | Okklusives pflaster mit flexibler backing |
| CN117159508B (zh) * | 2023-09-18 | 2024-11-15 | 湖南九典制药股份有限公司 | 热熔型贴剂及其制备方法 |
| CN120346189B (zh) * | 2025-06-23 | 2025-09-16 | 杭州百诚医药科技股份有限公司 | 一种热熔型洛索洛芬钠贴剂及其制备方法 |
| CN121081428B (zh) * | 2025-11-11 | 2026-02-13 | 湖南迪诺制药股份有限公司 | 一种高稳定性氟比洛芬抗炎贴剂及其制备方法 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4158609A (en) * | 1975-09-23 | 1979-06-19 | Mueller Hans | Process for the continuous conversion of products by enzyme action |
| JPS5888334A (ja) * | 1981-11-20 | 1983-05-26 | Takasago Corp | 3−l−メントキシプロパン−1、2−ジオ−ル |
| JPS5951215A (ja) | 1982-09-14 | 1984-03-24 | Taisho Pharmaceut Co Ltd | 粘着性湿布剤 |
| US4895727A (en) * | 1985-05-03 | 1990-01-23 | Chemex Pharmaceuticals, Inc. | Pharmaceutical vehicles for exhancing penetration and retention in the skin |
| CH666621A5 (de) * | 1986-06-27 | 1988-08-15 | Ciba Geigy Ag | Topisch applizierbare pharmazeutische zusammensetzungen mit systemischer wirkung. |
| JPS6440420A (en) | 1987-08-04 | 1989-02-10 | Hisamitsu Pharmaceutical Co | Anti-inflammatory and analgesic tape agent for percutaneous administration |
| US5059189A (en) * | 1987-09-08 | 1991-10-22 | E. R. Squibb & Sons, Inc. | Method of preparing adhesive dressings containing a pharmaceutically active ingredient |
| US5750134A (en) * | 1989-11-03 | 1998-05-12 | Riker Laboratories, Inc. | Bioadhesive composition and patch |
| CA2072623C (en) * | 1989-11-03 | 2001-03-27 | Matthew T. Scholz | Bioadhesive composition and patch |
| AU637496B2 (en) * | 1990-04-24 | 1993-05-27 | Teijin Limited | Plaster |
| US5633192A (en) * | 1991-03-18 | 1997-05-27 | Boston University | Method for epitaxially growing gallium nitride layers |
| EP0607434B1 (en) * | 1991-08-30 | 1999-01-27 | Hisamitsu Pharmaceutical Co., Inc. | Anti-inflammatory analgesic plaster |
| JPH05331064A (ja) | 1992-05-26 | 1993-12-14 | Sekisui Chem Co Ltd | 消炎鎮痛貼付剤 |
| DE4336557C2 (de) * | 1993-05-06 | 1997-07-17 | Lohmann Therapie Syst Lts | Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung |
| AU676562B2 (en) * | 1993-05-19 | 1997-03-13 | Hisamitsu Pharmaceutical Co., Inc. | Solubilizing agent and external preparation containing the same |
| DE69526437T2 (de) * | 1994-05-18 | 2002-10-31 | Hisamitsu Pharmaceutical Co., Inc. | Transdermal verabreichbare zubereitung zur behandlung von störungen des harnlassens |
| US5869087A (en) | 1994-09-16 | 1999-02-09 | Hisamitsu Pharmaceutical Co., Inc. | Patch having a preparation for external use attached thereto |
| JP3908795B2 (ja) * | 1994-11-29 | 2007-04-25 | 久光製薬株式会社 | ケトチフェン含有経皮投与製剤 |
| DE69738825D1 (de) | 1996-12-06 | 2008-08-21 | Hisamitsu Pharmaceutical Co | Felbinac enthaltendes Pflaster |
| KR19990026792A (ko) | 1997-09-26 | 1999-04-15 | 김윤 | 디클로페낙 디에틸암모늄염을 함유한 매트릭스형 패취제제 |
| WO2001043729A1 (fr) * | 1999-12-15 | 2001-06-21 | Hisamitsu Pharmaceutical Co., Inc. | Preparations d'adhesifs |
| US6914169B1 (en) * | 2000-05-19 | 2005-07-05 | Hisamitsu Pharmaceutical., Inc. | Patch agent |
| CA2411950A1 (en) * | 2000-06-13 | 2002-12-09 | Hisamitsu Pharmaceutical Co., Inc. | Patch |
-
2001
- 2001-04-17 AT AT01919982T patent/ATE517614T1/de not_active IP Right Cessation
- 2001-04-17 US US10/258,022 patent/US20030149383A1/en not_active Abandoned
- 2001-04-17 BR BR0110178-1A patent/BR0110178A/pt not_active Application Discontinuation
- 2001-04-17 CN CNB01808284XA patent/CN1200696C/zh not_active Expired - Lifetime
- 2001-04-17 DK DK01919982.7T patent/DK1277466T3/da active
- 2001-04-17 ES ES01919982T patent/ES2367541T3/es not_active Expired - Lifetime
- 2001-04-17 WO PCT/JP2001/003283 patent/WO2001078690A1/ja not_active Ceased
- 2001-04-17 CA CA2406261A patent/CA2406261C/en not_active Expired - Lifetime
- 2001-04-17 EP EP01919982A patent/EP1277466B1/en not_active Expired - Lifetime
- 2001-04-17 JP JP2001575991A patent/JP4854163B2/ja not_active Expired - Lifetime
- 2001-04-17 PT PT01919982T patent/PT1277466E/pt unknown
- 2001-04-17 KR KR1020027013873A patent/KR100600456B1/ko not_active Expired - Lifetime
- 2001-04-18 TW TW090109315A patent/TWI283587B/zh not_active IP Right Cessation
-
2009
- 2009-06-10 US US12/457,410 patent/US8173156B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1424908A (zh) | 2003-06-18 |
| KR100600456B1 (ko) | 2006-07-13 |
| EP1277466A1 (en) | 2003-01-22 |
| JP4854163B2 (ja) | 2012-01-18 |
| CA2406261C (en) | 2010-12-07 |
| KR20020089476A (ko) | 2002-11-29 |
| CA2406261A1 (en) | 2002-10-17 |
| TWI283587B (en) | 2007-07-11 |
| US20090258952A1 (en) | 2009-10-15 |
| US8173156B2 (en) | 2012-05-08 |
| US20030149383A1 (en) | 2003-08-07 |
| ES2367541T3 (es) | 2011-11-04 |
| EP1277466A4 (en) | 2008-08-20 |
| EP1277466B1 (en) | 2011-07-27 |
| WO2001078690A1 (en) | 2001-10-25 |
| ATE517614T1 (de) | 2011-08-15 |
| CN1200696C (zh) | 2005-05-11 |
| BR0110178A (pt) | 2003-12-30 |
| PT1277466E (pt) | 2011-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1277466E (pt) | Emplastro contendo agente anti-inflamatório | |
| PE20030399A1 (es) | Formas de administracion de propiverina o sus sales farmaceuticamente aceptables con liberacion prolongada de la sustancia activa | |
| NO20051854L (no) | Vedvarende frigivelse opioidformuleringer og fremgangsmater for anvendelse. | |
| HUP0100801A2 (hu) | Metformin és fibrát kombinációját tartalmazó gyógyászati készítmények és ezek alkalmazása kórosan magas vércukorszint csökkentését célzó gyógyszerek előállítására | |
| ATE176153T1 (de) | Entzündungshemmendes, analgetisches pflaster | |
| NO20052479L (no) | Tramadolformuleringer med forsinket frigjoring og 24 timers effektivitet | |
| EA200800931A1 (ru) | Твёрдые пероральные фармацевтические композиции для введения один раз в сутки, содержащие прегабалин, матрицеобразующий агент и агент набухания | |
| BRPI0016368B8 (pt) | emplastro. | |
| NO20001567L (no) | Bioadhesive sammensetninger og fremgangsmÕter for topisk administrering av aktive midler | |
| AU3475097A (en) | Substituted cyclopentane compounds useful as neuraminidase inhibitors | |
| DK1185253T3 (da) | Oralt præparat til indgivelse af en fast kombination af tramadol og diclofenac | |
| EA200001201A3 (ru) | Таблетка с основой, позволяющая осуществлять пролонгированное высвобождение триметазидина после введения оральным путем | |
| EE9800435A (et) | H+, K+-ATPaasi inhibiitorite manustamise reziim | |
| KR950008534A (ko) | 트리펩티드 항혈전제 | |
| ATE357928T1 (de) | Pharmazeutische zusammensetzung für thrombinpeptidderivaten | |
| GT200600307A (es) | Formas de dosificacion de liberacion retardada oral altamente biodisponibles de succinato de o-desmetilvenlafaxina | |
| CA2386793A1 (en) | New selective retinoid agonists | |
| FR2796844B1 (fr) | Nouvelle utilisation de solutions salines hypoosmotiques et medicament a base de ces solutions | |
| BR9910678A (pt) | Composto, composição farmacêutica, método para traramento ou prevenção de uma doença inflamatória, método para tratamento de uma condição ou uma doença mediada por mmps, tnf, agrecanase, ou um composto dos mesmos, em um mamìfero, método de redução de nìveis de tnf em pacientes, sem a inibição de mmps, método para tratamento de uma condição ou uma doença e uso de um novo composto | |
| CA2415154A1 (en) | Modified release formulations of selective serotonin re-uptake inhibitors | |
| DK1300143T3 (da) | Plaster som indeholder 4-biphenyleddikesyre | |
| NO983444L (no) | Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer | |
| JP2004083462A5 (da) | ||
| DK0910379T3 (da) | Plaster til transdermal påføring af pergolid | |
| JP2005535635A5 (da) |